A dosimetric comparison of brachytherapy sources for endometrial cancer: an electronic brachytherapy and an iridium-192 source with multichannel cylinders and a three-dimensional technique-Reference-Cited by-同舟云学术

A dosimetric comparison of brachytherapy sources for endometrial cancer: an electronic brachytherapy and an iridium-192 source with multichannel cylinders and a three-dimensional technique

Published:2024-08-22 Issue:1 Volume:24 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Wang Wenhui,Wang Bei,Yu Lang,Zhen Hongnan,Zhang Yue,Feng Siqi,Chen Zhou,Zhang Yuan,Qiu Jie,Zhang Fuquan,Hu Ke

Funder

National High Level Hospital Clinical Research Funding

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12885-024-12814-5.pdf

Reference23 articles.

1. Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2021;31(1):12–39.

2. Dickler A, Kirk MC, Coon A, Bernard D, Zusag T, Rotmensch J, et al. A dosimetric comparison of Xoft Axxent Electronic Brachytherapy and iridium-192 high-dose-rate brachytherapy in the treatment of endometrial cancer. Brachytherapy. 2008;7(4):351–4.

3. Mobit PN, Nguyen A, Packianathan S, He R, Yang CC. Dosimetric comparison of brachytherapy sources for high-dose-rate treatment of endometrial cancer: (192)ir, (60)Co and an electronic brachytherapy source. Br J Radiol. 2016;89(1059):20150449.

4. Dickler A, Puthawala MY, Thropay JP, Bhatnagar A, Schreiber G. Prospective multicenter trial utilizing electronic brachytherapy for the treatment of endometrial cancer. Radiation Oncol (London England). 2010;5:67.

5. Dooley WC, Thropay JP, Schreiber GJ, Puthawala MY, Lane SC, Wurzer JC, et al. Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study. OncoTargets Therapy. 2010;3:197–203.